Kambiz Nael | Mount Sinai

Biography

Multi-Disciplinary Training Area

Neuroscience [NEU]

Research

Anti-Tumor Therapy, Blood-Brain Barrier, Brain Imaging, Computational Neuroscience, Computed Tomography, Diffusion Tensor Imaging, Imaging, MRI, Magnetic Resonance Imaging, Neuroscience, Spinal Cord, Stroke

1. Cerebrovascular disorders:

- Application of MR perfusion techniques (DSC and ASL) in better understanding the pathophysiology of cerebrovascular disorders

- Evaluation of collateral flow in patients with acute ischemic stroke using perfusion biomarkers

- Prediction of intracranial hemorrhage in patients with acute ischemic stroke using combined MR diffusion and perfusion biomarkers

- Advanced multimodal MR imaging paradigm (DSC, fMRI, MR OEF) for better detection and prediction of future risk of stroke in patients with TIA

2. Quantitative multiparametric MRI analysis towards predictive modeling in patients with brain tumors:

- Differentiation of solitary brain metastasis from GBM: A predictive model using combined MR diffusion and perfusion

- Differentiation of radiation necrosis from recurrent high grade glioma using multi parametric MRI

- Multiparametric MRI in distinguishing pseudoprogression vs. true progression in intracranial metastases treated with radiation

Honors & Awards

2015

Travel Awward for Junior Investigators

International Stroke Conference, Nashville,TN

2015

Distinguished Reviewer

American Journal of Neuroradiology

2011

Roentgen Resident/Fellow Research Award

RSNA Research & Education Foundation

Publications

140

Publications

Selected Publications

Pretreatment parameters associated with hemorrhagic transformation among successfully recanalized medium vessel occlusions. Manisha Koneru, Meisam Hoseinyazdi, Richard Wang, Burak Berksu Ozkara, Nathan Z. Hyson, Elisabeth Breese Marsh, Rafael H. Llinas, Victor C. Urrutia, Richard Leigh, Luis Fernando Gonzalez, Risheng Xu, Justin M. Caplan, Judy Huang, Hanzhang Lu, Licia Luna, Max Wintermark, Adam A. Dmytriw, Adrien Guenego, Gregory W. Albers, Jeremy J. Heit, Kambiz Nael, Argye E. Hillis, Vivek S. Yedavalli. Journal of Neurology

Redefining CT perfusion-based ischemic core estimates for the ghost core in early time window stroke. Manisha Koneru, Meisam Hoseinyazdi, Dhairya A. Lakhani, Cynthia Greene, Karen Copeland, Richard Wang, Risheng Xu, Licia Luna, Justin M. Caplan, Adam A. Dmytriw, Adrien Guenego, Jeremy J. Heit, Gregory W. Albers, Max Wintermark, Luis F. Gonzalez, Victor C. Urrutia, Judy Huang, Kambiz Nael, Richard Leigh, Elisabeth B. Marsh, Argye E. Hillis, Rafael H. Llinas, Vivek S. Yedavalli. Journal of Neuroimaging

The Relative Cerebral Blood Volume (rCBV) < 42% Is Independently Associated with Collateral Status in Anterior Circulation Large Vessel Occlusion. Dhairya A. Lakhani, Aneri B. Balar, Manisha Koneru, Sijin Wen, Burak Berksu Ozkara, Hanzhang Lu, Richard Wang, Meisam Hoseinyazdi, Janet Mei, Risheng Xu, Mehreen Nabi, Ishan Mazumdar, Andrew Cho, Kevin Chen, Sadra Sepehri, Nathan Hyson, Victor Urrutia, Licia Luna, Argye E. Hillis, Jeremy J. Heit, Greg W. Albers, Ansaar T. Rai, Adam A. Dmytriw, Tobias Faizy, Max Wintermark, Kambiz Nael, Vivek S. Yedavalli. Journal of Clinical Medicine

View All Publications

Office Locations

Klingenstein Pavillion Floor MC - Level

1176 5th Ave

New York, NY 10029

212-241-8333

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Nael has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Nael has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.